Status:
COMPLETED
Cognitive Function in Patients With Persisted Atrial Fibrillation
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Atrial Fibrillation, Persistent
Cognitive Function
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Compare the difference of cognitive function between different treatment strategy in patients with persistent atrial fibrillation
Detailed Description
The prevalence of atrial fibrillation (AF) had been increasing for the past decade. The increase of AF was attributed to the aging of the population and the increased awareness of the disease among pe...
Eligibility Criteria
Inclusion
- Those who meet the diagnosis of persistent atrial fibrillation, meet one of the following conditions:
- The twelve-lead electrocardiogram is used to diagnose atrial fibrillation, and to cooperate with clinical diagnosis.
- 24 hours ECG diagnosis 100% atrial fibrillation, with clinical diagnosis.
- The seven-day ECG recorder diagnosed 100% atrial fibrillation.
- Willing to accept treatment recommended by doctors, containing anticoagulant, and cooperate with examination and treatment in the coming year.
Exclusion
- Unwilling to sign the clinical trial consent form.
- Unable to complete the cognitive function questionnaire.
- Unable to complete brain MRI examination due to various reasons
Key Trial Info
Start Date :
November 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 26 2025
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04508491
Start Date
November 30 2020
End Date
February 26 2025
Last Update
July 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan